Answers are grounded in this paper and cite their sources.
Biomarkers for prognostication need large randomised controlled trials such as AspECT and BOSS. These trials will deliver surrogates which fulfil the validation criteria necessary for their introduction into the clinic
No takes yet. Share an insight, caveat, or question.
Sean Preston (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: